Showing results (281-290 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|June 13, 2008
How long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART?Robert Gross, Warren B Bilker, Hao Wang, et al.
HIV Clinical Trials|June 13, 2008
Higher plasma myeloperoxidase levels are not associated with an increased risk for cardiovascular events in HIV-infected adultsDalia El-Bejjani, Stanley L Hazen, Wilma Mackay, et al.
HIV Clinical Trials|May 14, 2008
Efficacy and safety of 48 weeks of enfuvirtide 180 mg once-daily dosing versus 90 mg twice-daily dosing in HIV-infected patientsDavid Wright, Allen Rodriguez, Eliot Godofsky, et al.
HIV Clinical Trials|May 14, 2008
Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIVAnn C Collier, Camlin Tierney, Gerald F Downey, et al.
HIV Clinical Trials|May 14, 2008
Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapyGrace A McComsey, Minhee Kang, Allison C Ross, et al.
HIV Clinical Trials|April 9, 2014
Aerobic fitness levels and validation of a non exercise VO2max prediction equation for HIV-infected patients on HAARTKatherine Sullivan, Cecilia M Shikuma, Dominic Chow, et al.
HIV Clinical Trials|November 29, 2007
Evaluation of Stool frequency and stool form as measures of HIV-related diarrheaJill Tinmouth, George Tomlinson, Gabor Kandel, et al.
HIV Clinical Trials|November 29, 2007
The Incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naïve participants started on three different antiretroviral therapy strategiesMichael J Kozal, Katherine Huppler Hullsiek, Rodger D Macarthur, et al.
HIV Clinical Trials|February 15, 2014
Phase I study demonstrates safety and tolerability of radiofrequency ablation (RFA) of the anal mucosaA George Smulian, Diana M Moore, Jaime C Robertson, et al.
HIV Clinical Trials|January 25, 2008
Seven-year efficacy of a lopinavir/ritonavir-based regimen in antiretroviral-naïve HIV-1-infected patientsRobert L Murphy, Barbara A da Silva, Charles B Hicks, et al.
Pageof 68